These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29720352)

  • 1. Bacteremia and meningitis caused by OXA-23-producing Acinetobacter baumannii - molecular characterization and susceptibility testing for alternative antibiotics.
    Schuertz KF; Tuon FF; Palmeiro JK; Conte D; Telles JPM; Trevisoli LE; Dalla-Costa LM
    Braz J Microbiol; 2018 Nov; 49 Suppl 1(Suppl 1):199-204. PubMed ID: 29720352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
    Lowings M; Ehlers MM; Dreyer AW; Kock MM
    BMC Infect Dis; 2015 Nov; 15():521. PubMed ID: 26573617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
    Cakirlar FK; Ciftci IH; Gonullu N
    Clin Lab; 2015; 61(7):741-7. PubMed ID: 26299073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital.
    Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA
    J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of colistin against multidrug-resistant Acinetobacter baumannii isolates harboring blaOXA-23-like and blaOXA-24-like genes: A multicenter based study.
    Khanjani S; Sedigh Ebrahim-Saraie H; Shenagari M; Ashraf A; Mojtahedi A; Atrkar Roushan Z
    Acta Microbiol Immunol Hung; 2020 Mar; 67(3):182-186. PubMed ID: 32160785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of oxacillinases and genotyping of invasive Acinetobacter baumannii isolates using repetitive extragenic palindromic sequence-based polymerase chain reaction in Ankara between 2004 and 2010.
    Ergin A; Hascelik G; Eser OK
    Scand J Infect Dis; 2013 Jan; 45(1):26-31. PubMed ID: 22978782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of NDM and OXA-type carbapenemases to carbapenem resistance in clinical
    Ogbolu DO; Alli OAT; Oluremi AS; Ogunjimi YT; Ojebode DI; Dada V; Alaka OO; Foster-Nyarko E; Webber MA
    Infect Dis (Lond); 2020 Sep; 52(9):644-650. PubMed ID: 32516021
    [No Abstract]   [Full Text] [Related]  

  • 10. First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
    Al-Agamy MH; Jeannot K; El-Mahdy TS; Shibl AM; Kattan W; Plésiat P; Courvalin P
    Microb Drug Resist; 2017 Jul; 23(5):556-562. PubMed ID: 27854148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
    Seifert H; Stefanik D; Sutcliffe JA; Higgins PG
    Int J Antimicrob Agents; 2018 Jan; 51(1):62-64. PubMed ID: 28705668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
    Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM
    Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acinetobacter baumannii clonal lineages I and II harboring different carbapenem-hydrolyzing-β-lactamase genes are widespread among hospitalized burn patients in Tehran.
    Mahdian S; Sadeghifard N; Pakzad I; Ghanbari F; Soroush S; Azimi L; Rastegar-Lari A; Giannouli M; Taherikalani M
    J Infect Public Health; 2015; 8(6):533-42. PubMed ID: 26111484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
    Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
    J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.
    Lee MH; Chen TL; Lee YT; Huang L; Kuo SC; Yu KW; Hsueh PR; Dou HY; Su IJ; Fung CP
    J Microbiol Immunol Infect; 2013 Dec; 46(6):419-24. PubMed ID: 23010539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Susceptibility and Molecular Characterization of Clinical Strains of
    Shah MW; Yasir M; Farman M; Jiman-Fatani AA; Almasaudi SB; Alawi M; El-Hossary D; Azhar EI
    Microb Drug Resist; 2019 Nov; 25(9):1297-1305. PubMed ID: 31216221
    [No Abstract]   [Full Text] [Related]  

  • 19. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.
    Agodi A; Voulgari E; Barchitta M; Quattrocchi A; Bellocchi P; Poulou A; Santangelo C; Castiglione G; Giaquinta L; Romeo MA; Vrioni G; Tsakris A
    J Hosp Infect; 2014 Apr; 86(4):260-6. PubMed ID: 24680473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
    Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
    Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.